Sinovac Biotech Ltd (NASDAQ:SVA)
| -- Delayed Data As of -- | -- -- / -- Today’s Change | -- |||52-Week Range -- | -- Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $745.3M |
Company Description
Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.
Contact Information
Sinovac Biotech Ltd. No. 39 Shangdi Xi Road Beijing Beijing 100085 |
Employees
Shareholders
| Mutual fund holders | 0.00% |
| Other institutional | 0.00% |
| Individual stakeholders | -- |
Top Executives
| Wei Dong Yin | Chairman, President, CEO, Secretary & MD |
| Qiang Gao | Chief Operating Officer & Vice President |
| Nan Wang | CFO & Vice President-Business Development |
| Xiao Mei Yin | Vice President-Sales & Marketing |
| Coco Chang | Head-International Sales |
